Gibson, Dunn & Crutcher LLP is advising Apogee Therapeutics, Inc. in the offering.Apogee Therapeutics, Inc. (Nasdaq: APGE) announced the pricing of its upsized initial public offering of…
Standard 1 Year Membership Required
You must be a Standard 1 Year member to access this content.
Already a member? Log in here
